Endotoxemia in rats--influence of lipoxygenase blocker versus leukotriene receptor antagonist (BW755C vs LY171883).
Bahrami
S
S
Ludwig Boltzmann Institute for Experimental Traumatology, Vienna, Austria.
Paul
E
E
Redl
H
H
Schlag
G
G
Mihm
F
F
D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; D000098:Acetophenones / Q000494:pharmacology*; D000818:Animals; D001393:Azoles / Q000494:pharmacology*; D004731:Endotoxins / Q000097:blood*; D007958:Leukocyte Count; D016859:Lipoxygenase Inhibitors; D008297:Male; D010976:Platelet Count; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D018077:Receptors, Leukotriene; D011982:Receptors, Prostaglandin / Q000187:drug effects; D013777:Tetrazoles / Q000494:pharmacology*; D013929:Thromboxane B2 / Q000097:blood; D014115:Toxemia / Q000097:blood / Q000209:etiology* / Q000517:prevention & control
D000098:Acetophenones; D001393:Azoles; D004731:Endotoxins; D016859:Lipoxygenase Inhibitors; D011720:Pyrazoles; D018077:Receptors, Leukotriene; D011982:Receptors, Prostaglandin; D013777:Tetrazoles; D013929:Thromboxane B2; D015772:4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; C044660:LY 171883